基本信息
浏览量:2
职业迁徙
个人简介
I am an enthusiastic immunologist with strong background in molecular biology techniques, including transcriptional profiling and vaccine development (Cruz JL et al., J Virol, 2013; Cruz JL et al., PloS Pathogens, 2011). I have been developing my professional, research and project management skills, as well as contributing intellectually and technically on several diverse academic and industry-based projects, since I began my PhD.
I obtained a 4-year PhD Scholarship from the Community of Madrid where I worked in the development of genetically modified vaccines to protect against viral diseases in collaboration with Pfizer®'s animal healthcare division (Cruz JL et.,Virus Res, 2010). In parallel, I described a novel mechanism employed by RNA viruses to evade host innate immunity and modulate the host anti-viral transcriptional profile (Cruz JL et al.,PloS Pathogens, 2011; Cruz et al, J Virol, 2013). During this time I published 6 papers, 3 as a first author in highly rated journals, such as PLOs Pathogens and J. Virology.
I focused on mechanisms that govern the initiation of the adaptive immune response at the natural portal of entry of human viruses, such as the respiratory tract (influenza A virus, IAV) and the skin surface (Rift Valley Fever virus, RVFV), work that led to two publications, including a J. Immunology and one as a first author in the European J. of Immunology. ([…] Cruz JL, et al.,J Immunol, 2014; Cruz et al., Europ J Immunol, 2016).
My research was focused on the development of novel immunotherapies/vaccines for virally associated cancers by regulating the function of cytotoxic T-cells. In 2016, I was awarded with the 3-year UQ-postdoctoral fellowship. During my time at the institute I have received the UQ Travel Award (2016), the UQDI Early career Travel Award (2017) and the Keystone Symposium Travel Award (2017).
In 2019, I was awarded with a 3-year Garnet Passe and Rodney Williams Memorial Foundation co-joint grant with Prof. Christopher Perry at Princess Alexandra hospital. Currently, mentored by Professor Ian Frazer, I lead a collaboration project with the Technological University of Denmark and Princess Alexandra Hospital to develop a pipeline to de-risk the design and manufacture of personalized cancer immunotherapies. Our group will be the first in Australia to apply large-scale DNA barcode-labelled multimers and single cell sequencing to identify anti-tumour T-cells in patients with HPV16+/- Oropharyngeal Squamous Cell carcinoma (OPSCC), and test the efficacy of novel patient-specific vaccines containing tumour antigens known to mount an anti-tumour response.
In the last years, I have expanded my field of expertise to innate and adaptive/T-cell immunology, animal models to test immunotherapies and Head and Neck cancers, including HPV-related tumours, Squamous Cell Carcinoma (SCC), particularly Oropharyngeal SCC (Cruz JL et al., Exp Dermatol, 2016; Cruz et al., Oncotarget, 2018). My recent work has led to a ground-breaking method based on flow-activated-cytometry sorting for the purification and characterization of a T-cell subset that regulates cytotoxic T-cell in the skin (Cruz JL et al., J Leukocyte Biology, 2017).
I successfully collaborate on interdisciplinary projects in Australia and overseas, including professional collaborations with Dr. Fiona Simpson (Translational Research Institute, Brisbane), with Dr. Roberta Mazzieri and Prof. Richardo Dolcetti (TRI, Brisbane), with Prof. Nicole La Gruta (Monash University, Melbourne), with A/Prof. Scott Byrne (Sydney Medical School), with Prof. Sine Reker Hadrup (National Veterinary Institute, Technical University of Denmark, Copenhagen), with Juan Carlos Oliveros and Dr. Silvia Gutierrez (National Centre of Biotechnology, Madrid), and an industrial collaboration with Jingang and Vaxxas (Brisbane).
I am an active member of the scientific community at the University of Queensland participating as member of several committees, such as SBMS honours student, Educational training and UQDI BRF committees, and I externally contribute by acting as an expert in the evaluation of Spanish research projects.
I collaborate with Australian Cervical Cancer Foundation (ACCF) acting as an awareness ambassador and I volunteer for Precious Paws Animal Rescue (PPAR) providing a home to dogs in need until they find their FURever family.
I obtained a 4-year PhD Scholarship from the Community of Madrid where I worked in the development of genetically modified vaccines to protect against viral diseases in collaboration with Pfizer®'s animal healthcare division (Cruz JL et.,Virus Res, 2010). In parallel, I described a novel mechanism employed by RNA viruses to evade host innate immunity and modulate the host anti-viral transcriptional profile (Cruz JL et al.,PloS Pathogens, 2011; Cruz et al, J Virol, 2013). During this time I published 6 papers, 3 as a first author in highly rated journals, such as PLOs Pathogens and J. Virology.
I focused on mechanisms that govern the initiation of the adaptive immune response at the natural portal of entry of human viruses, such as the respiratory tract (influenza A virus, IAV) and the skin surface (Rift Valley Fever virus, RVFV), work that led to two publications, including a J. Immunology and one as a first author in the European J. of Immunology. ([…] Cruz JL, et al.,J Immunol, 2014; Cruz et al., Europ J Immunol, 2016).
My research was focused on the development of novel immunotherapies/vaccines for virally associated cancers by regulating the function of cytotoxic T-cells. In 2016, I was awarded with the 3-year UQ-postdoctoral fellowship. During my time at the institute I have received the UQ Travel Award (2016), the UQDI Early career Travel Award (2017) and the Keystone Symposium Travel Award (2017).
In 2019, I was awarded with a 3-year Garnet Passe and Rodney Williams Memorial Foundation co-joint grant with Prof. Christopher Perry at Princess Alexandra hospital. Currently, mentored by Professor Ian Frazer, I lead a collaboration project with the Technological University of Denmark and Princess Alexandra Hospital to develop a pipeline to de-risk the design and manufacture of personalized cancer immunotherapies. Our group will be the first in Australia to apply large-scale DNA barcode-labelled multimers and single cell sequencing to identify anti-tumour T-cells in patients with HPV16+/- Oropharyngeal Squamous Cell carcinoma (OPSCC), and test the efficacy of novel patient-specific vaccines containing tumour antigens known to mount an anti-tumour response.
In the last years, I have expanded my field of expertise to innate and adaptive/T-cell immunology, animal models to test immunotherapies and Head and Neck cancers, including HPV-related tumours, Squamous Cell Carcinoma (SCC), particularly Oropharyngeal SCC (Cruz JL et al., Exp Dermatol, 2016; Cruz et al., Oncotarget, 2018). My recent work has led to a ground-breaking method based on flow-activated-cytometry sorting for the purification and characterization of a T-cell subset that regulates cytotoxic T-cell in the skin (Cruz JL et al., J Leukocyte Biology, 2017).
I successfully collaborate on interdisciplinary projects in Australia and overseas, including professional collaborations with Dr. Fiona Simpson (Translational Research Institute, Brisbane), with Dr. Roberta Mazzieri and Prof. Richardo Dolcetti (TRI, Brisbane), with Prof. Nicole La Gruta (Monash University, Melbourne), with A/Prof. Scott Byrne (Sydney Medical School), with Prof. Sine Reker Hadrup (National Veterinary Institute, Technical University of Denmark, Copenhagen), with Juan Carlos Oliveros and Dr. Silvia Gutierrez (National Centre of Biotechnology, Madrid), and an industrial collaboration with Jingang and Vaxxas (Brisbane).
I am an active member of the scientific community at the University of Queensland participating as member of several committees, such as SBMS honours student, Educational training and UQDI BRF committees, and I externally contribute by acting as an expert in the evaluation of Spanish research projects.
I collaborate with Australian Cervical Cancer Foundation (ACCF) acting as an awareness ambassador and I volunteer for Precious Paws Animal Rescue (PPAR) providing a home to dogs in need until they find their FURever family.
研究兴趣
论文共 26 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PIGMENT CELL & MELANOMA RESEARCHno. 1 (2024)
Cellsno. 16 (2023): 2094-2094
Pigment Cell & Melanoma Research (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn